Internal Reference Number: FOI_7546
Date Request Received: 10/11/2023 00:00:00
Date Request Replied To: 20/11/2023 00:00:00
This response was sent via: By Email
Request Summary: MRI scans
Request Category: Companies
Question Number 1: Please provide the above information for the five financial years ending 2021/22. The number of MRI scans performed for the following, Central Nervous System • Brain • Spine • Other Surrounding Tissue • Whole Body • Head & Neck • Thorax, including Breast • Abdomen, including Liver & Kidneys • Pelvis, including Prostate • Musculo-skeletal system • Other • Cardiac • Angiography | |
Answer To Question 1: Please see our response to this FOI in the spreadsheet attached. Please note, we are unable to answer questions 4 and 5 as this information is not reliably recorded. To accompany this answer to question 1 please also see the documents listed below: 11810 - FOI_7546 - MRI Scans For issue.xlsx | |
Question Number 2: The number of MRI scans for the above listed investigations using a macrocyclic gadolinium contrast agent(s) | |
Answer To Question 2: Please see our response to this FOI in the spreadsheet attached. Please note, we are unable to answer questions 4 and 5 as this information is not reliably recorded. | |
Question Number 3: The average number of doses of a macrocyclic gadolinium contrast agent(s) per scan | |
Answer To Question 3: Please see our response to this FOI in the spreadsheet attached. Please note, we are unable to answer questions 4 and 5 as this information is not reliably recorded. | |
Question Number 4: The number of rescans, which are performed due to the outcome of a poor-quality image when using a macrocyclic gadolinium contrast agent in the initial scan. | |
Answer To Question 4: Please see our response to this FOI in the spreadsheet attached. Please note, we are unable to answer questions 4 and 5 as this information is not reliably recorded. | |
Question Number 5: The number of rereports required due to the outcome of a poor-quality image when using a macrocyclic gadolinium contrast agent in the initial scan. | |
Answer To Question 5: Please see our response to this FOI in the spreadsheet attached. Please note, we are unable to answer questions 4 and 5 as this information is not reliably recorded. | |
Please see Attachments: | |
To return to the list of all the FOI requests please click here |
Our staff at SA¹ú¼Ê´«Ã½ Hospital have long been well regarded for the quality of care and treatment they provide for our patients and for their innovation, commitment and professionalism. This has been recognised in a wide range of achievements and it is reflected in our award of NHS Foundation Trust status. This is afforded to hospitals that provide the highest standards of care.